Harvard Apparatus Regenerative Technology, Inc.
HRGN- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001563665
In the last 90 days, Harvard Apparatus Regenerative Technology, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Harvard Apparatus Regenerative Technology, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- 0 vs. Q1 2026
- Shares held
- 0
- 0 vs. Q1 2026
- Total value
- $0
- $0 vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Holders and value by quarter
Institutions reporting HRGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 1 | $58.0K |
| Q1 2022 | 1 | $76.0K |
| Q4 2021 | 1 | $42.0K |
| Q3 2021 | 1 | $55.0K |
| Q2 2021 | 1 | $31.0K |
| Q1 2021 | 1 | $34.0K |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Harvard Apparatus Regenerative Technology, Inc.; share changes are against Q1 2026.
No institution reported holding HRGN in Q2 2026.